2009
DOI: 10.1021/mp900150g
|View full text |Cite
|
Sign up to set email alerts
|

Efficient Delivery of Antisense Oligodeoxyribonucleotide G3139 by Human Serum Albumin-Coated Liposomes

Abstract: Human serum albumin (HSA)-coated liposomal formulations were synthesized and evaluated for the delivery of antisense oligodeoxyribonucleotide (ODN) G3139 in KB human oral carcinoma cells. Liposomes composed of dimethyldioctadecyl ammonium bromide/egg phosphatidylcholine/α-tocopheryl polyethylene glycol 1000 succinate (58:40:2 molar ratio) complexed with G3139 and coated with HSA were investigated for Bcl-2 down regulating activity. Cellular uptake of HSA-coated liposome-ODN complexes was more efficient than th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(19 citation statements)
references
References 24 publications
0
19
0
Order By: Relevance
“…The materialisation of the idea of interfering with expressions/activities of specific Bcl-2 targets in cancerous cells challenges us to develop a complete understanding of the behaviour of Bcl-2 proteins in response to different anticancer agents in various neoplasms. Although use of antisense oligonucleotides has been challenged with efficient drug delivery issues in clinical trials, significant achievements of non-peptidic small molecule inhibitors (SMI) of antiapoptotic Bcl-2 proteins are ensuring the acceleration of efforts to design Bcl-2 manipulation-based therapeutic approaches [37][44].…”
Section: Discussionmentioning
confidence: 99%
“…The materialisation of the idea of interfering with expressions/activities of specific Bcl-2 targets in cancerous cells challenges us to develop a complete understanding of the behaviour of Bcl-2 proteins in response to different anticancer agents in various neoplasms. Although use of antisense oligonucleotides has been challenged with efficient drug delivery issues in clinical trials, significant achievements of non-peptidic small molecule inhibitors (SMI) of antiapoptotic Bcl-2 proteins are ensuring the acceleration of efforts to design Bcl-2 manipulation-based therapeutic approaches [37][44].…”
Section: Discussionmentioning
confidence: 99%
“…As a result, the liposome collapses and fuses with the endosomal membrane which then leads to release of liposome contents into the cytoplasm 2 . Cellular uptake of HSA (human serum albumin)-coated liposome-ODN complexes used for Bcl-2 mRNA downregulation in KB (HeLa derivative) human oral carcinoma cells was found to be about three-fold higher compared to uncoated liposomes, and six-fold higher than naked As-ODNs 24 . Targeted action towards specific cells can be achieved by conjugating folate or transferrin to the liposome to assist receptor-mediated endocytosis.…”
Section: Liposomesmentioning
confidence: 98%
“…In another approach, BSA-coated liposomes were thermally denatured (DBL) and encapsulated with the drug doxorubicin. The DBLs showed higher intracellular uptake and stability in plasma in comparison to Doxil Õ , Titusville, NJ (Weecharangsan et al, 2009). …”
Section: Lipid Npsmentioning
confidence: 99%